Evidence map›Paper›PMID 35719933›Full record

ArticleFrontiers in oncology2022

The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study.

Hsin-Chih Yeh, Chao-Hsiang Chang, Jen-Kai Fang, I-Hsuan Alan Chen, Jen-Tai Lin, Jian-Hua Hong, Chao-Yuan Huang, Shian-Shiang Wang, Chuan-Shu Chen, Chi-Wen Lo and 16 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 19 institutions in 1 country.

Hsin-Chih YehDepartment of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
Chao-Hsiang ChangDepartment of Urology, China Medical University, Taichung, Taiwan.
Jen-Kai FangDepartment of Urology, China Medical University Hospital, Taichung, Taiwan.
I-Hsuan Alan ChenDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Jen-Tai LinDivision of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Jian-Hua HongInstitute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan.
Chao-Yuan HuangDepartment of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Shian-Shiang WangDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Chuan-Shu ChenDivision of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.
Chi-Wen LoDivision of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei City, Taiwan.
Chih-Chin YuDivision of Urology, Department of Surgery, Taipei Tzu Chi Hospital, The Buddhist Medical Foundation, New Taipei City, Taiwan.
Jen-Shu TsengDepartment of Urology, MacKay Memorial Hospital, Taipei, Taiwan.
Wun-Rong LinDepartment of Urology, MacKay Memorial Hospital, Taipei, Taiwan.
Yeong-Chin JouDepartment of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Ian-Seng CheongDepartment of Urology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Yuan-Hong JiangDepartment of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.
Chung-You TsaiDivision of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Thomas Y HsuehDivision of Urology, Department of Surgery, Taipei City Hospital renai branch, Taipei, Taiwan.
Yung-Tai ChenDepartment of Urology, Taiwan Adventist Hospital, Taipei, Taiwan.
Hsu-Che HuangDivision of Urology, Department of Surgery, Cardinal Tien Hospital, New Taipei City, Taiwan.
Yao-Chou TsaiDepartment of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Wei-Yu LinDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chia-Chang WuDepartment of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Po-Hung LinDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Te-Wei LinSchool of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wen-Jeng WuDepartment of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chiayi Chang Gung Memorial Hospital · TWChia-Yi Christian Hospital · TWChina Medical University · TWKaohsiung Medical University · TWKaohsiung Veterans General Hospital · TWNational Taiwan University Hospital · TWTzu Chi University · TWCardinal Tien Hospital · TWChang Gung Memorial Hospital · TWFar Eastern Memorial Hospital · TWKaohsiung Municipal Ta-Tung Hospital · TWNational Chi Nan University · TWNational Taichung University of Science and Technology · TWNational Yang Ming Chiao Tung University · TWTaipei City Hospital · TWTaipei Medical University · TWTaipei Medical University Hospital · TWTaipei Tzu Chi Hospital · TWTaiwan Adventist Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We aimed to evaluate the impact of preoperative local symptoms on prognosis after radical nephroureterectomy in patients with upper tract urothelial carcinoma (UTUC). Methods: This retrospective study consisted of 2,662 UTUC patients treated at 15 institutions in Taiwan from 1988 to 2019. Clinicopathological data were retrospectively collected for analysis by the Taiwan UTUC Collaboration Group. The Kaplan-Meier method was used to calculate overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and bladder recurrence-free survival (BRFS). The prognostic value of preoperative local symptoms in OS, CSS, DFS, and BRFS was investigated using Cox proportional hazards models. Results: The median follow-up was 36.6 months. Among 2,662 patients, 2,130 (80.0%) presented with hematuria and 398 (15.0%) had symptomatic hydronephrosis at diagnosis. Hematuria was associated with less symptomatic hydronephrosis ( Conclusions: Preoperative local symptoms were significantly associated with oncological outcomes, whereas symptomatic hydronephrosis and hematuria had opposite prognostic effects. Preoperative symptoms may provide additional information on risk stratification and perioperative treatment selection for patients with UTUC.

Indexed as

flank painhematuriaprognosisradical nephroureterectomy (RNU)symptomatic hydronephrosisupper tract urothelial carcinoma (UTUC)

Identifiers

PMID35719933
PMCPMC9201473
OpenAlexW4281783107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.